P

Inventor

PALANI ANANDAN

US70 patents
⚠️ This page may combine multiple inventors who share the name “PALANI ANANDAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

18 patents
US6689765B2Feb 10, 2004

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP71 citations97
US6391865B1May 21, 2002

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP94 citations97
US7049320B2May 23, 2006

NK1 antagonists

SCHERING CORP54 citations96
US6387930B1May 14, 2002

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP76 citations96
US6900329B2May 31, 2005

MCH antagonists and their use in the treatment of obesity

SCHERING CORP18 citations92
US6602885B2Aug 5, 2003

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP21 citations92
US7045636B2May 16, 2006

MCH antagonists for the treatment of obesity

SCHERING CORP35 citations89
US7763623B2Jul 27, 2010

Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia

SCHERING CORP9 citations82
US7384944B2Jun 10, 2008

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP6 citations73
US7723342B2May 25, 2010

Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia

SCHERING CORP4 citations63
US7442703B2Oct 28, 2008

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP2 citations63
US7384948B2Jun 10, 2008

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP4 citations63
US7737155B2Jun 15, 2010

Nitrogen-containing heterocyclic compounds and methods of use thereof

SCHERING CORP2 citations62
US7354922B2Apr 8, 2008

Bridged ring NK1 antagonists

SCHERING CORP4 citations62
US7750015B2Jul 6, 2010

Nitrogen-containing heterocyclic compounds and methods of use thereof

SCHERING CORP2 citations61
US8034933B2Oct 11, 2011

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP0 citations52
US7498438B2Mar 3, 2009

Fused ring NK1 antagonists

SCHERING CORP0 citations52
US7452891B2Nov 18, 2008

MCH antagonists and their use in the treatment of obesity

SCHERING CORP0 citations52

MERCK SHARP & DOHME

8 patents

OPKO HEALTH INC

6 patents

HUANG XIANHAI

3 patents

MERCK SHARP & DOHME LLC

3 patents

MCCOMAS CASEY C

2 patents

ASLANIAN ROBERT G

2 patents

ZHU ZHAONING

2 patents

SCHERING PLOUGH CORP

1 patent

PALIWAL SUNIL

1 patent

HE SHUWEN

1 patent

SHAH SAPNA S

1 patent

BOYCE CHRISTOPHER W

1 patent

CHENG CLIFFORD

1 patent

Showing the top 50 of 70 patents by PatentIndex Score.